Tumor Necrosis Factor Receptor 1 Expression Is Upregulated in Dendritic Cells in Patients with Chronic HCV Who Respond to Therapy
Figure 1
TNFR1 and TNFR2 mRNA levels were not different between HCV()/ALD/NAFLD control patients and genotype 1 patients prior to treatment. TNFR1 mRNA levels of PBMC’s isolated from 10 HCV() controls, 11 ALD/NAFLD controls, and 23 HCV+ patients prior to therapy were ascertained by real time PCR (Panel A). TNFR2 mRNA levels of PBMC’s isolated from 10 HCV() controls, 5 ALD/NAFLD controls, and 18 patients prior to therapy were ascertained by real time PCR (Panel B). Statistical differences were assessed by - test.
